Li‐Anne Lim

478 total citations
36 papers, 260 citations indexed

About

Li‐Anne Lim is a scholar working on Ophthalmology, Molecular Biology and Oncology. According to data from OpenAlex, Li‐Anne Lim has authored 36 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Ophthalmology, 11 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Li‐Anne Lim's work include Ocular Oncology and Treatments (29 papers), Retinal Diseases and Treatments (8 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Li‐Anne Lim is often cited by papers focused on Ocular Oncology and Treatments (29 papers), Retinal Diseases and Treatments (8 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Li‐Anne Lim collaborates with scholars based in United States, Australia and Canada. Li‐Anne Lim's co-authors include Carol L. Shields, Lauren A. Dalvin, Jerry A. Shields, Mehdi Mazloumi, Arman Mashayekhi, David Ancona‐Lezama, Michael Chang, Miguel N. Burnier, E. Antecka and Bruno F. Fernandes and has published in prestigious journals such as Journal of Clinical Oncology, Stroke and Neurosurgery.

In The Last Decade

Li‐Anne Lim

31 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li‐Anne Lim United States 10 187 64 63 56 49 36 260
Florian Rensch Germany 14 330 1.8× 68 1.1× 44 0.7× 15 0.3× 87 1.8× 21 440
Wei-Chi Wu Taiwan 9 81 0.4× 26 0.4× 19 0.3× 11 0.2× 71 1.4× 31 260
Kelvin Y. C. Lee Singapore 9 215 1.1× 11 0.2× 20 0.3× 82 1.5× 148 3.0× 10 312
Carolina Bernal-Morales Spain 11 106 0.6× 58 0.9× 11 0.2× 35 0.6× 177 3.6× 26 380
Mads Krüger Falk Denmark 15 490 2.6× 32 0.5× 7 0.1× 19 0.3× 99 2.0× 24 581
Yusuke Ichiyama Japan 10 285 1.5× 8 0.1× 35 0.6× 11 0.2× 59 1.2× 20 366
Jaume Crespí Spain 8 110 0.6× 8 0.1× 14 0.2× 13 0.2× 99 2.0× 15 255
Baptiste Ameline Switzerland 11 34 0.2× 44 0.7× 15 0.2× 25 0.4× 121 2.5× 27 303

Countries citing papers authored by Li‐Anne Lim

Since Specialization
Citations

This map shows the geographic impact of Li‐Anne Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Anne Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Anne Lim more than expected).

Fields of papers citing papers by Li‐Anne Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐Anne Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Anne Lim. The network helps show where Li‐Anne Lim may publish in the future.

Co-authorship network of co-authors of Li‐Anne Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Anne Lim. A scholar is included among the top collaborators of Li‐Anne Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Anne Lim. Li‐Anne Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joshua, Anthony M., Roderick O’Day, William Glasson, et al.. (2024). A phase 2 safety and efficacy study of neoadjuvant/adjuvant darovasertib for localized ocular melanoma.. Journal of Clinical Oncology. 42(16_suppl). 9510–9510. 4 indexed citations
2.
Hesson, Luke B., Vivian Lin, Dale Wright, et al.. (2024). Microdissection of Distinct Morphological Regions Within Uveal Melanomas Identifies Novel Drug Targets. Cancers. 16(24). 4152–4152.
3.
Dalvin, Lauren A., Hamid Riazi‐Esfahani, Fariba Ghassemi, et al.. (2023). Pediatric ocular melanoma: a collaborative multicenter study and meta-analysis. Journal of American Association for Pediatric Ophthalmology and Strabismus. 27(6). 316–324. 1 indexed citations
4.
Zhu, Xue, Ke Wang, Svetlana Cherepanoff, et al.. (2023). Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells. Journal of Cancer. 14(18). 3477–3495. 1 indexed citations
5.
Lim, Li‐Anne, David Ancona‐Lezama, Mehdi Mazloumi, et al.. (2020). Wide-Field (15 × 9 mm) Swept-Source Optical Coherence Tomography Angiography Following Plaque Radiotherapy of Choroidal Melanoma: An Analysis of 105 eyes. Asia-Pacific Journal of Ophthalmology. 9(4). 326–334. 8 indexed citations
6.
Sweid, Ahmad, Kareem El Naamani, Batoul Hammoud, et al.. (2020). Incidence and predictors of ophthalmic artery occlusion in intra-arterial chemotherapy for retinoblastoma. Journal of NeuroInterventional Surgery. 13(7). 652–656. 9 indexed citations
7.
Dalvin, Lauren A., Li‐Anne Lim, David Ancona‐Lezama, et al.. (2020). Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology Center. Asia-Pacific Journal of Ophthalmology. 9(2). 110–116. 15 indexed citations
8.
Mashayekhi, Arman, Lauren A. Dalvin, Li‐Anne Lim, et al.. (2020). ASSOCIATION OF VITREORETINAL LYMPHOMA WITH SYSTEMIC LYMPHOMA. Retina. 41(2). 259–265. 10 indexed citations
9.
Ly, David, Duo Wang, Robert M. Conway, et al.. (2020). Lipid-Producing Ciliochoroidal Melanoma with Expression of HMG-CoA Reductase. Ocular Oncology and Pathology. 6(6). 416–421.
10.
Lim, Li‐Anne, et al.. (2019). Retinoblastoma regression following intra-arterial chemotherapy to the contralateral eye. Saudi Journal of Ophthalmology. 33(3). 291–293.
11.
Dalvin, Lauren A., Li‐Anne Lim, Michael Chang, et al.. (2019). Circumscribed choroidal hemangioma: Clinical features and outcomes by age category in 458 cases. Saudi Journal of Ophthalmology. 33(3). 219–228. 9 indexed citations
12.
Chang, Michael, Lauren A. Dalvin, Li‐Anne Lim, et al.. (2019). Prophylactic Intravitreal Bevacizumab after Plaque Radiotherapy for Uveal Melanoma: Analysis of 1311 Eyes of 1310 Patients by Age. Investigative Ophthalmology & Visual Science. 60(9). 721–721.
13.
Shields, Carol L., Lauren A. Dalvin, Li‐Anne Lim, et al.. (2019). Visual acuity outcomes in Coats disease by classification stage in 160 patients. British Journal of Ophthalmology. 104(3). 422–431. 18 indexed citations
14.
Dalvin, Lauren A., Li‐Anne Lim, Mehdi Mazloumi, et al.. (2019). Predictors of enucleation in Coats disease: analysis of 259 eyes of 259 patients at a single center. Journal of American Association for Pediatric Ophthalmology and Strabismus. 23(5). 266.e1–266.e9. 7 indexed citations
15.
Dalvin, Lauren A., Li‐Anne Lim, David Ancona‐Lezama, et al.. (2019). Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub–Retinal Pigment Epithelium Infiltration. Ophthalmology Retina. 3(11). 998–1005. 11 indexed citations
16.
Khoo, Chloe T. L., Lauren A. Dalvin, Li‐Anne Lim, et al.. (2019). Factors Predictive of Subretinal Fluid Resolution in Coats Disease: Analysis of 177 Eyes in 177 Patients at a Single Center. Asia-Pacific Journal of Ophthalmology. 8(4). 290–297. 5 indexed citations
17.
Symes, Richard J., John H. Chang, Li‐Anne Lim, et al.. (2019). UVEITIS CAUSED BY TREATMENT FOR MALIGNANT MELANOMA: A CASE SERIES. Retinal Cases & Brief Reports. 15(6). 718–723. 7 indexed citations
18.
Lim, Li‐Anne, et al.. (2018). Idiopathic full thickness macular hole in a 10-year-old girl. International Journal of Retina and Vitreous. 4(1). 25–25. 3 indexed citations
19.
Lim, Li‐Anne, et al.. (2018). Episcleral racemose hemangioma. Journal of American Association for Pediatric Ophthalmology and Strabismus. 23(2). 111–113.
20.
Lim, Li‐Anne, et al.. (2014). Case report: an atypical peripapillary uveal melanoma. BMC Ophthalmology. 14(1). 13–13. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Florian Rensch Breakdown of academic impact, for papers by Wei-Chi Wu Breakdown of academic impact, for papers by Kelvin Y. C. Lee Breakdown of academic impact, for papers by Carolina Bernal-Morales Breakdown of academic impact, for papers by Mads Krüger Falk Breakdown of academic impact, for papers by Yusuke Ichiyama Breakdown of academic impact, for papers by Jaume Crespí Breakdown of academic impact, for papers by Baptiste Ameline
Rankless by CCL
2026